Analysis and Commentary 5/8/21 Analysis and Commentary 5/8/21 FDA Priorities for FY 22 Read More Advocacy at a Glance 5/8/21 Advocacy at a Glance 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Advocacy at a Glance 4/23/21 Advocacy at a Glance 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More Analysis and Commentary 4/23/21 Analysis and Commentary 4/23/21 Alliance "Hill Day": April 28 and 29 Read More Analysis and Commentary 4/16/21 Analysis and Commentary 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More 4/12/21 4/12/21 President's Budget Preview for FY 22 Read More Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Analysis and Commentary 3/27/21 Analysis and Commentary 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary 3/19/21 Analysis and Commentary 3/19/21 Two Topical Political Issues Read More Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More 3/19/21 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Analysis and Commentary 3/13/21 Analysis and Commentary 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Newer Posts Older Posts
Advocacy at a Glance 5/8/21 Advocacy at a Glance 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Advocacy at a Glance 4/23/21 Advocacy at a Glance 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More
Analysis and Commentary 4/23/21 Analysis and Commentary 4/23/21 Alliance "Hill Day": April 28 and 29 Read More
Analysis and Commentary 4/16/21 Analysis and Commentary 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary 3/27/21 Analysis and Commentary 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary 3/19/21 Analysis and Commentary 3/19/21 Two Topical Political Issues Read More
Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Analysis and Commentary 3/13/21 Analysis and Commentary 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More
Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
